Icon

PROAMATINE (nda019815)- (2.5MG,5MG,10MG)

MIDODRINE HYDROCHLORIDE TAKEDA PHARMS USA
2.5MG,5MG,10MG
No No
Expired Expired
None None
None No
ProAmatineĀ® is indicated for the treatment of symptomatic orthostatic hypotension (OH). Because ProAmatineĀ® can cause marked elevation of supine blood pressure (BP>200 mmHg systolic), it should be used in patients whose lives are considerably impaired despite standard clinical care, including non-pharmacologic treatment (such as support stockings), fluid expansion, and lifestyle alterations.
13 0 12
Total Other Developers None
Drugs with Suitability No
2.5MG ** ** - - 12
5MG ** ** - - 12
10MG ** ** - - 12
NDA Sales Available Total Generic Sales Available
No 12
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ****** *** ********** *** *** *********** ** ****** **, ****** ****, *** ****, ********* (***) ***
****** ****** ***** **** ******-***** ************, *** *********** ***** **** *** *, ********, ********* (**) *****-****, ****** ****** (***) ***
****** ****** ****** ***. *********** ** ******** ****., *********, ******* *** ***, ****** (***) ***
****** ***** *****-*** *** * * ********* *** *************** ******* *********** **** **. ***-***, *.*.*.* ********** ****, *******, ******, ***** (***) ***
****** ******* ********, ***. *********** *** ********* *** ***** **, ****** *******, *** **** (**) *****, ****** ****** (***) ***
****** ******* ******* ******** ******* ******* *********** **** ** *-**/* & ***/*, ****, ********** ********* ****,, *****, *********** *** ***, ***** (***) ***
****** ********* ****** *** *** ********** ******* *********** ****-**, **** **.**, *****, *.*.***, ******** *******, ********* ******, ******** ********, ********, ****** ******* ******, ***** (***) ***
****** ***** ************ ***** ************ ******* *********** **** **. *-*/*&* *******, (******* ******** ****) ******, ******* ***** *.*. **. **, ***-******, ****-*********, *********, ******* ******, ***** (***) ***
****** ******* ******* *************** ******* *********** *********** ********, ******* *******, *.*. *******, **** *****, ****** *****,, **********, ******* ******, ***** (***) ***
****** ******* ******* ****** ***. ***. *********** ** **, ***** ******* ********* *, ***** ********* ****** **** *, ****** **** ******, ****** ******** *****, ******** (***) ***
****** ******* ****** ******* ****** ******* *********** ****-***, ******* *****, ****** **** ****, ***. ****** *******, ****** *****, *******, ******** ******* ******, ***** (***) ***
****** ***** ****** *** ***** *************** ***. *********** **** ******* ***** ****, **********, **** ******** (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.